Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02126124 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.
A Phase 3 study, sponsored by Brainsway.
- Completed
- Registry status
- Phase 3
- Development phase
- 224
- Enrollment target
NCT02126124 is a Phase 3 study that has completed, run by Brainsway. The registered enrollment target is 224 participants.
The verdict
NCT02126124, a Phase 3 study, has completed, sponsored by Brainsway.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 224 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of DTMS compared to sham treatment as an aid to smoking cessation in chronic, heavy (\>10 cigarettes/day) cigarette smokers.
Interventions
- DEVICE Sham Treatment
- DEVICE Active dTMS Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2014-08-20 |
| Est. Completion | 2019-11-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02126124
The ClinicalTrials.gov registry entry for NCT02126124 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brainsway, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment is the first listed.
NCT02126124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02126124 about?
NCT02126124 is a clinical study titled "Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.". The purpose of the study is to evaluate the safety and efficacy of DTMS compared to sham treatment as an aid to smoking cessation in chronic, heavy (\>10 cigarettes/day) cigarette smokers.
What is the current status of trial NCT02126124?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 224 participants. The study started on 2014-08-20. Estimated completion is 2019-11-14.
What interventions are being tested in trial NCT02126124?
The interventions under investigation include: Sham Treatment (DEVICE), Active dTMS Treatment (DEVICE).
Who is sponsoring clinical trial NCT02126124?
This trial is sponsored by Brainsway, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.